Rebecca Perlow, DO
Obstetrics · Tarzana, CANPI 1346235157
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 30.2% of the total.
Across 254 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$510
- Pfizer$431
- Therapeuticsmd, Inc.$404
- Mayne Pharma Commercial LLC$285
- Myovant Sciences Inc.$248
- plus $1K from 20 others
What the payments were for
- Consulting fees$2004%
- Food & beverage$4,32794%
- Education$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 122 | $1,387 |
| Novo Nordisk | 16 | $510 |
| Pfizer | 30 | $431 |
| Therapeuticsmd, Inc. | 15 | $404 |
| Mayne Pharma Commercial LLC | 14 | $285 |
| Myovant Sciences Inc. | 16 | $248 |
| Mimedx Group, Inc. | 1 | $200 |
| Evofem Biosciences, Inc. | 8 | $151 |
| Exact Sciences | 3 | $141 |
| Organon | 1 | $122 |
| Coopersurgical, Inc. | 1 | $89 |
| Lilly USA, LLC | 3 | $88 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Exeltis, USA Inc. | 4 | $86 |
| Davol Inc. | 1 | $74 |
| AMAG Pharmaceuticals, Inc. | 2 | $44 |
| Bayer | 2 | $43 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Lupin Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Roche Diagnostics Corporation | 1 | $20 |
| IBSA Pharma Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $17 |
| Avion Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$227
- The Cologuard Plus Collection Kit$122
- BIJUVA$122
- Saxenda$122
- Orilissa$115
How this compares
$4,587 in reported general payments places this provider in the 85th percentile of 119 obstetrics providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 11 | $181 |
| Atorvastatin Calcium | 11 | $140 |
| Fluoxetine Hcl | 16 | $29 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Tarzana
- Peter WangGarden Grove$428K
- Douglas Woelkersla Jolla$57K
- Richard FriedmanBurbank$18K
- Jennifer ByerSanta Rosa$17K
- Omar AzizEl Centro$14K
- Frederica LofquistSan Francisco$14K
- Craig SafferSan Diego$14K
- Caitlyn PainterSan Francisco$10K
- Kay DanielsStanford$9K
- Joie RussoEncino$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.